|
| 22/12/2008 |
TAKEDA COMMENCE CETILISTAT (ATL-962) PHASE III PROGRAMME IN JAPAN |
|
| 19/11/2008 |
Interim Management Statement |
|
| 16/09/2008 |
Takeda Milestone Payment |
|
| 05/09/2008 |
Update on Board Change |
|
| 29/08/2008 |
Interim Results for the six months ended 30 June 2008 |
|
| 24/07/2008 |
Alizyme Announces Headline Results From its European Phase III Clinical Trial of Colal-PredŽ |
|
| 27/06/2008 |
Alizyme Licenses COLAL-PREDŽ to Norgine |
|
| 24/06/2008 |
Annual General Meeting 2008 |
|
| 24/06/2008 |
Alizyme plc 2008 AGM Voting results |
|
| 20/06/2008 |
Alizyme to present at the 2008 Piper Jaffray Europe Conference |
|
| 12/06/2008 |
Alizyme to Present at the 2008 Bio International Convention |
|
| 20/05/2008 |
Interim Management Statement |
|
| 20/05/2008 |
Commencement of Phase II Study For Colal-PredŽ in the US |
|
| 23/04/2008 |
Results from Renzapride |
|
| 22/04/2008 |
2007 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION |
|
| 06/03/2008 |
CETILISTAT PHASE III DEVELOPMENT PLAN |
|
| 06/03/2008 |
INSTITUTIONAL PLACING |
|
| 06/03/2008 |
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2006 |
|
| 07/01/2008 |
PRODUCT & COMPANY UPDATE |
|
Help